Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Filament Health Corp.
  6. Summary
    FLHLF   CA31685W1068

FILAMENT HEALTH CORP.

(FLHLF)
  Report
Delayed Quote. Delayed OTC Markets - 01/21 01:13:19 pm
0.178325 USD   +7.30%
01/14Filament health and cybin therapeutics announce licensing agreement
AQ
01/14Filament Health Corp. Enters into Licensing Agreement with Cybin Therapeutics
CI
01/05IIROC Trade Resumption - FH
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
01/14/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
0.2999(c) 0.1967(c) 0.1715(c) 0.16619(c) 0.178325(c) Last
11 200 2 500 13 452 500 1 905 Volume
+11.49% -34.41% -12.81% -3.10% +7.30% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -4,06 M - -
Net Debt 2021 - - -
P/E ratio 2021 -4,57x
Yield 2021 -
Sales 2022 0,41 M - -
Net income 2022 -8,03 M - -
Net Debt 2022 - - -
P/E ratio 2022 -3,79x
Yield 2022 -
Capitalization 29,4 M 29,4 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 71,2x
Nbr of Employees -
Free-Float -
More Financials
Company
Filament Health Corp. is a Canada-based natural psychedelic drug discovery and development company. The Company is engaged in natural extraction technologies utilizing patented and patent-pending processes to manufacture pharmaceutical grade psychoactive products. The Company operates through its Health Canada Dealer's license at its good manufacturing practice (GMP) drug discovery and manufacturing facility. The... 
More about the company
All news about FILAMENT HEALTH CORP.
01/14Filament health and cybin therapeutics announce licensing agreement
AQ
01/14Filament Health Corp. Enters into Licensing Agreement with Cybin Therapeutics
CI
01/05IIROC Trade Resumption - FH
AQ
01/05Filament health recognizes the restoration of access to restricted drugs via the health..
AQ
01/05IIROC Trading Halt - FH
AQ
01/04Filament health announces health canada approval for phase ii trial administering new p..
AQ
01/04Filament Health Corp. Announces Health Canada Approval for Phase II Clinical Trial Admi..
CI
2021Filament Health to Participate in Key Psychedelics Conferences in December 2021
AQ
2021Filament Health Corp. Announces Co-Development and Exclusive Licensing Agreement with E..
CI
2021Filament Health Reports Third Quarter 2021 Financial Results and Operational Highlights
AQ
2021Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct Ps..
AQ
2021Filament Health Corp. Announces FDA Authorization of Clinical Trial with First-Ever Dir..
CI
2021KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie..
AQ
2021FILAMENT HEALTH : to Webcast Live at VirtualInvestorConferences.com October 14th
PR
2021FILAMENT HEALTH : Announces DTC Eligibility and Up-List to the OTCQB Exchange
AQ
More news
News in other languages on FILAMENT HEALTH CORP.
01/14Filament Health Corp. conclut un accord de licence avec Cybin Therapeutics
01/04Filament Health Corp. Annonce l'approbation de Santé Canada pour un essai clinique de p..
More news
Chart FILAMENT HEALTH CORP.
Duration : Period :
Filament Health Corp. Technical Analysis Chart | FLHLF | CA31685W1068 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,18 $
Average target price 1,50 $
Spread / Average Target 741%
EPS Revisions
Managers and Directors
Benjamin Lightburn Chief Executive Officer & Director
Tom Kineshanko President
Warren Duncan Chief Financial Officer
James Gregory Mills Chairman
Ryan Moss Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
FILAMENT HEALTH CORP.-21.53%29
THERMO FISHER SCIENTIFIC-13.03%228 678
DANAHER CORPORATION-14.76%200 403
INTUITIVE SURGICAL, INC.-24.98%96 286
SIEMENS HEALTHINEERS AG-7.72%77 272
EDWARDS LIFESCIENCES CORPORATION-13.05%70 331